Comparisons between the HCT-CI and the CCI in the validation set (n = 347) for events within first 2 years
. | HCT-CI for 3 risk groups . | CCI for 3 risk groups . | P* . |
|---|---|---|---|
| Nonrelapse mortality | |||
| c-statistic (SE*), overall | 0.649 (0.029) | 0.520 (0.019) | < .001 |
| c-statistic (SE*), yes/no 2 y | 0.685 (0.037) | 0.532 (0.023) | < .001 |
| c-statistic (SE*), yes/no 1 y | 0.692 (0.036) | 0.546 (0.025) | < .001 |
| Likelihood ratio | 26.6 | 1.2 | |
| Adjusted likelihood ratio† | 21.4 | 0.7 | |
| Overall survival | |||
| c-statistic (SE*), overall | 0.624 (0.021) | 0.536 (0.015) | < .001 |
| c-statistic (SE*), yes/no 2 y | 0.657 (0.031) | 0.548 (0.019) | < .001 |
| c-statistic (SE*), yes/no 1 y | 0.661 (0.030) | 0.561 (0.021) | < .001 |
| Likelihood ratio | 31.8 | 7.6 | |
| Adjusted likelihood ratio† | 23.7 | 7.1 |
. | HCT-CI for 3 risk groups . | CCI for 3 risk groups . | P* . |
|---|---|---|---|
| Nonrelapse mortality | |||
| c-statistic (SE*), overall | 0.649 (0.029) | 0.520 (0.019) | < .001 |
| c-statistic (SE*), yes/no 2 y | 0.685 (0.037) | 0.532 (0.023) | < .001 |
| c-statistic (SE*), yes/no 1 y | 0.692 (0.036) | 0.546 (0.025) | < .001 |
| Likelihood ratio | 26.6 | 1.2 | |
| Adjusted likelihood ratio† | 21.4 | 0.7 | |
| Overall survival | |||
| c-statistic (SE*), overall | 0.624 (0.021) | 0.536 (0.015) | < .001 |
| c-statistic (SE*), yes/no 2 y | 0.657 (0.031) | 0.548 (0.019) | < .001 |
| c-statistic (SE*), yes/no 1 y | 0.661 (0.030) | 0.561 (0.021) | < .001 |
| Likelihood ratio | 31.8 | 7.6 | |
| Adjusted likelihood ratio† | 23.7 | 7.1 |